Vise Technologies Inc. Boosts Holdings in Cardinal Health, Inc. $CAH

Vise Technologies Inc. lifted its stake in Cardinal Health, Inc. (NYSE:CAHFree Report) by 91.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,782 shares of the company’s stock after purchasing an additional 4,193 shares during the quarter. Vise Technologies Inc.’s holdings in Cardinal Health were worth $1,805,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. Aventura Private Wealth LLC purchased a new position in shares of Cardinal Health in the 4th quarter worth about $25,000. Elyxium Wealth LLC purchased a new position in shares of Cardinal Health in the 4th quarter worth about $34,000. Barnes Dennig Private Wealth Management LLC raised its position in shares of Cardinal Health by 38.7% in the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock worth $39,000 after purchasing an additional 53 shares during the last quarter. JPL Wealth Management LLC purchased a new position in shares of Cardinal Health in the 3rd quarter worth about $31,000. Finally, Turning Point Benefit Group Inc. purchased a new position in shares of Cardinal Health in the 3rd quarter worth about $31,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Barclays boosted their target price on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. Robert W. Baird set a $248.00 target price on Cardinal Health in a research report on Friday, May 1st. JPMorgan Chase & Co. decreased their target price on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research report on Monday, May 4th. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday. Finally, TD Cowen boosted their target price on Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $241.80.

View Our Latest Analysis on CAH

Cardinal Health Stock Up 0.0%

Cardinal Health stock opened at $205.79 on Monday. The business has a 50-day simple moving average of $202.53 and a two-hundred day simple moving average of $208.59. The company has a market cap of $48.20 billion, a P/E ratio of 31.47, a P/E/G ratio of 1.12 and a beta of 0.52. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60.

Cardinal Health (NYSE:CAHGet Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Research analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is presently 31.19%.

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

See Also

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.